These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33046806)

  • 1. Effects of olanzapine treatment on lipid profiles in patients with schizophrenia: a systematic review and meta-analysis.
    Li R; Zhang Y; Zhu W; Ding C; Dai W; Su X; Dai W; Xiao J; Xing Z; Huang X
    Sci Rep; 2020 Oct; 10(1):17028. PubMed ID: 33046806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid profile in schizophrenia: case control study.
    Mhalla A; Bel Hadj Salah W; Mensi R; Amamou B; Messaoud A; Gassab L; Douki W; Najjar MF; Gaha L
    Tunis Med; 2018 Jan; 96(1):22-29. PubMed ID: 30324988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect on lipid profiles of switching from olanzapine to another second-generation antipsychotic agent in veterans with schizophrenia.
    Garman PM; Ried LD; Bengtson MA; Hsu C; McConkey JR
    J Am Pharm Assoc (2003); 2007; 47(3):373-8. PubMed ID: 17510032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of blood cell counts with the risk of olanzapine- or clozapine-induced dyslipidemia in Chinese schizophrenia patients.
    Xiong Z; Cheng M; Zhu P; Huang S; Guo J; Zhang W; Zhou H; Shu Y; Li Q
    Hum Psychopharmacol; 2019 Jul; 34(4):e2699. PubMed ID: 31273857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of fasting blood sugar and serum lipid profile changes after treatment with atypical antipsychotics olanzapine and risperidone.
    Kaushal J; Bhutani G; Gupta R
    Singapore Med J; 2012 Jul; 53(7):488-92. PubMed ID: 22815019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum lipid profiles and schizophrenia: effects of conventional or atypical antipsychotic drugs in Taiwan.
    Huang TL; Chen JF
    Schizophr Res; 2005 Dec; 80(1):55-9. PubMed ID: 15964176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of ziprasidone and olanzapine on glucose and lipid metabolism in first-episode schizophrenia].
    Shao P; Ou J; Wu R; Fang M; Chen H; Xu Y; Zhao J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 38(4):365-9. PubMed ID: 23645236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum IL-1ra, a novel biomarker predicting olanzapine-induced hypercholesterolemia and hyperleptinemia in schizophrenia.
    Lin Y; Peng Y; He S; Xu J; Shi Y; Su Y; Zhu C; Zhang X; Zhou R; Cui D
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):71-78. PubMed ID: 29410009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of lurasidone versus olanzapine on cardiometabolic parameters in unmedicated patients with schizophrenia: a randomized controlled trial.
    Jena M; Mishra A; Mishra BR; Nath S; Maiti R
    Psychopharmacology (Berl); 2020 Nov; 237(11):3471-3480. PubMed ID: 32740676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of olanzapine and risperidone on lipid metabolism in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized five month study.
    Smith RC; Lindenmayer JP; Hu Q; Kelly E; Viviano TF; Cornwell J; Vaidhyanathaswamy S; Marcovina S; Davis JM
    Schizophr Res; 2010 Jul; 120(1-3):204-9. PubMed ID: 20457512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic variation in ApoC3, ApoA5 and LPL genes and first and second generation antipsychotic effects on serum lipids in patients with schizophrenia.
    Smith RC; Segman RH; Golcer-Dubner T; Pavlov V; Lerer B
    Pharmacogenomics J; 2008 Jun; 8(3):228-36. PubMed ID: 17726453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of long-term aripiprazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: a 52-week, open-label comparison with olanzapine.
    Chrzanowski WK; Marcus RN; Torbeyns A; Nyilas M; McQuade RD
    Psychopharmacology (Berl); 2006 Dec; 189(2):259-66. PubMed ID: 17058105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective comparison of weight, lipid, and glucose changes between risperidone- and olanzapine-treated inpatients: metabolic outcomes after 1 year.
    Meyer JM
    J Clin Psychiatry; 2002 May; 63(5):425-33. PubMed ID: 12019668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomic mapping of atypical antipsychotic effects in schizophrenia.
    Kaddurah-Daouk R; McEvoy J; Baillie RA; Lee D; Yao JK; Doraiswamy PM; Krishnan KR
    Mol Psychiatry; 2007 Oct; 12(10):934-45. PubMed ID: 17440431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-sectional comparison of fasting lipids in normoglycemic patients with schizophrenia during chronic treatment with olanzapine, risperidone, or typical antipsychotics.
    Hardy TA; Marquez E; Kryzhanovskaya L; Taylor CC; Cavazzoni P
    J Clin Psychopharmacol; 2006 Aug; 26(4):405-8. PubMed ID: 16855460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latent Toxoplasma gondii infection is associated with decreased serum triglyceride to high-density lipoprotein cholesterol ratio in male patients with schizophrenia.
    Sagud M; Vlatkovic S; Svob Strac D; Sviben M; Zivkovic M; Vilibic M; Vuksan-Cusa B; Mihaljevic-Peles A; Pivac N
    Compr Psychiatry; 2018 Apr; 82():115-120. PubMed ID: 29477703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-density lipoprotein-cholesterol and antipsychotic medication in overweight inpatients with schizophrenia: post-hoc analysis of a Japanese nationwide survey.
    Ono S; Sugai T; Suzuki Y; Yamazaki M; Shimoda K; Mori T; Ozeki Y; Matsuda H; Sugawara N; Yasui-Furukori N; Okamoto K; Sagae T; Someya T
    BMC Psychiatry; 2018 Jun; 18(1):180. PubMed ID: 29879941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A crossover study on lipid and weight changes associated with olanzapine and risperidone.
    Su KP; Wu PL; Pariante CM
    Psychopharmacology (Berl); 2005 Dec; 183(3):383-6. PubMed ID: 16240162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of metabolic changes in patients with schizophrenia during randomized treatment with intramuscular olanzapine long-acting injection versus oral olanzapine.
    McDonnell DP; Kryzhanovskaya LA; Zhao F; Detke HC; Feldman PD
    Hum Psychopharmacol; 2011 Aug; 26(6):422-33. PubMed ID: 21823172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of ghrelin alterations in schizophrenia: Effects of olanzapine.
    Goetz RL; Miller BJ
    Schizophr Res; 2019 Apr; 206():21-26. PubMed ID: 30528312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.